Stock Price
4.47
Daily Change
0.05 1.13%
Monthly
30.70%
Yearly
135.26%
Q2 Forecast
4.07

EDAP TMS reported EUR5.97M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AngioDynamics USD 44.78M 2.93M Sep/2025
Boston Scientific USD 3.61B 64M Mar/2026
EDAP TMS EUR 5.97M 850K Sep/2025
Henry Schein USD 1.07B 7M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Veracyte USD 101.16M 814K Mar/2026